Physician profile
Michael Yacoub
NPI 1972847671
$4,627.10
in general payments reported to CMS, 2019-2025
23 companies · $52.22 in 2025
The $52.22 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $493 · 2020: $50.52 · 2021: $225 · 2022: $1,686 · 2023: $590 · 2024: $1,530 · 2025: $52.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,089 · Food and Beverage: $1,083.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,088.65 |
| Food and Beverage | $1,083.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $2,980.74 | 2022-2024 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Excluder Aaa Endoprosthesis, Gore Tag Thoracic Endoprosthesis |
| Cook Medical LLC | $268.03 | 2019-2024 | Zenith Spiral-Z |
| Cardiovascular Systems INC. | $176.94 | 2019 | |
| Shockwave Medical, INC | $164.41 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Silk Road Medical, INC. | $150.77 | 2020-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Terumo Medical Corporation | $130.14 | 2019-2020 | |
| Biotissue Holdings INC. | $129.52 | 2023 | |
| Medtronic Vascular, INC. | $128.08 | 2019 | |
| Integra Lifesciences Corporation | $84.52 | 2019-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Boston Scientific Corporation | $76.97 | 2024-2025 | Ranger, Enroute Transcarotid Neuroprotection System |
| Medtronic, INC. | $41.59 | 2021-2023 | Endurant Iis |
| Penumbra, INC. | $41.17 | 2022-2024 | Penumbra System |
| Abbott Laboratories | $34.48 | 2023-2025 | Esprit, Jeti Peripheral Catheter |
| Lemaitre Vascular, INC. | $32.30 | 2023 | Hydro Lemaitre Valvulotome, Xenosure Biologic Patch |
| Getinge USA Sales, LLC | $29.68 | 2024 | Vasoview Hemopro 2 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $25.30 | 2021-2022 | |
| Zimmer Biomet Holdings, INC. | $24.41 | 2021 | |
| Atricure, INC. | $21.43 | 2023 | |
| Abiomed | $21.13 | 2023 | Impella |
| Cvrx, INC. | $21.04 | 2022 | |
| Reflow Medical INC | $17.70 | 2023 | |
| Janssen Pharmaceuticals, INC | $14.04 | 2023 | Xarelto |
| Edwards Lifesciences Corporation | $12.71 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Yacoub listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.